Introduction {#s1}
============

Neutrophils are the most abundant white blood cell in the circulation and serve as the first line of host defence against pathogen attack. They are terminally differentiated, short lived cells that emerge from the bone marrow ready to react to the presence of pathogens ([@bib2]; [@bib32]). Once a foreign molecule or endogenous threat is identified the neutrophil has a battery of mechanisms it can deploy to insure optimum removal of the hazard. These include the ability to phagocytose, degranulate and produce reactive oxygen species (ROS). The neutrophil can also produce chemokines and cytokines to alert other cells in the vicinity to the danger and thus maximise the host's immune response ([@bib46]).

Another form of defence utilised by the neutrophil is the release of decondensed chromatin decorated with antimicrobial peptides that can capture the pathogen in a process termed neutrophil extracellular trap (NET) formation ([@bib6]). NETosis has been primarily examined in response to phorbol 12-myristate 13-acetate (PMA), a potent mitogen and a robust NET inducer. Neutrophils also initiate NETosis in response to microbial infections and, similarly to PMA, these activate protein kinase C (PKC), which in turn leads to calcium fluxes within the cell and activation of the NADPH oxidase signalling cascade resulting in the production of reactive oxygen species (ROS) ([@bib22]; [@bib28]). The hydrogen peroxide (H~2~O~2~) produced is in turn consumed by myeloperoxidase (MPO) to produce hypochlorous acid as well as other oxidants ([@bib42]). The production of ROS is responsible for the activation of the azurosome, a protein complex composed of MPO, the serine protease neutrophil elastase (NE) and cathepsin G among other granular proteins. The generation of oxidants by MPO liberates NE from the azurosome, allowing it to translocate to the nucleus where it aids in the decondensation of the chromatin by proteolyzing histones ([@bib40]). Finally, the cytoplasmic milieu mixes with the nuclear material as the nuclear and subsequently the plasma membrane break down, resulting in release of the NET.

This study describes the different pathways leading to NETs by comparing the induction of NETosis by several stimuli. Primary neutrophils from healthy donors were treated with five stimuli: (1) PMA, (2) the calcium ionophore A23187, (3) the bacterial toxin nigericin that acts as a potassium ionophore, (4) the dimorphic fungus *Candida albicans* and (5) the gram-positive bacteria Group B Streptococcus (GBS) and examined for the production of NETs. We tested a range of inhibitors against proteins involved in NETosis to clarify the essential elements in NET induction.

To study the role of ROS in NETosis, we tested neutrophils isolated from chronic granulomatous disease (CGD) patients. These patients have mutations in genes coding for subunits of the NADPH oxidase complex and as such their neutrophils cannot make ROS ([@bib25]). Thus, these patients are highly susceptible to bacterial and fungal infections. We also tested neutrophils from a patient with a mutation in MPO.

Citrullination is a post-transcriptional modification resulting in the conversion of arginine to citrulline and is catalysed by a group of calcium-dependent proteins known as peptidylarginine deiminases (PADs) ([@bib16]). Recent studies have shown that citrullination occurs during NETosis ([@bib34]). We therefore also investigated if histone H3 is citrullinated during the induction of NETosis in response to the different stimuli.

Finally, we showed that the NETs generated by the five stimuli have similar properties and that NETosis is a unique form of cell death, different from classical cell death pathways involving apoptosis and necroptosis.

Results {#s2}
=======

A wide range of stimuli induce neutrophil extracellular traps (NETs) {#s2-1}
--------------------------------------------------------------------

We selected five representative and well-described NET inducers that are effective over a 2.5--4 hr time period: (1) PMA, (2) the calcium ionophore A23187 which is produced during the growth of *Streptomyces chartreusensis*, (3) the potassium ionophore nigericin which is derived from the bacteria *Streptomyces hygroscopicus*, (4) *Candida albicans* hyphae and (5) *Streptococcus agalactiae* or Group B streptococcus (GBS) and examined NETosis ([Figure 1A](#fig1){ref-type="fig"}). We visualised and quantified NETs in samples that were fixed and stained with antibodies directed against a complex of histone 2A, histone 2B and chromatin ([@bib36]) and against neutrophil elastase (NE). Finally, the DNA was stained with the DNA-intercalating dye Hoechst 33342. We used the DNA stain to count the total number of neutrophils and NETs were quantified based on the presence of extracellular chromatin and a size exclusion protocol previously described ([@bib5]). Activating neutrophils with each of the stimuli resulted in a similar NET structure containing extracellular DNA co-localised with NE and chromatin ([Figure 1B--G](#fig1){ref-type="fig"}).10.7554/eLife.24437.003Figure 1.NETosis induction by a range of stimuli.Primary human neutrophils were stimulated for the indicated times with 50 nM PMA, 5 µM A23187, 15 µM nigericin, MOI 5 opsonized *C. albicans* or MOI 10 opsonized group B streptococcus (GBS), fixed with 2% PFA and incubated with a DNA stain (Hoechst) and immunolabeled with antibodies directed against Neutrophil Elastase (NE) and chromatin (**A--G**). (**A**) NETosis rate was quantified by immunofluorescence. Graph shows mean ± SEM from independent experiments with three different donors. (**B--G**) Representative confocal microscopy images of (**B**) non-stimulated neutrophils (-) or NETs induced by (**C**) PMA (**D**) A23187, (**E**) nigericin (**F**) *C. albicans* or (**G**) GBS and stained with Hoechst (blue) and immunolabeled for NE (green) and chromatin (red). Scale bars, 50 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.003](10.7554/eLife.24437.003)10.7554/eLife.24437.004Figure 1---source data 1.This data is the mean values of three independent NETosis assays in response to the five stimuli of interest and was used to generate the histogram in [Figure 1A](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.004](10.7554/eLife.24437.004)10.7554/eLife.24437.005Figure 1---figure supplement 1.NET induction over time with the five stimuli of interest.Primary human neutrophils were stimulated for the indicated times with 50 nM PMA (**B**), 5 µM A23187 (**C**), 15 µM nigericin (**D**), MOI 5 *C. albicans* (**E**) or MOI 10 GBS (**F**), fixed with 2% PFA and incubated with a DNA stain (Hoechst) and immunolabeled with antibodies directed against Neutrophil Elastase (NE) and chromatin. NETosis rate was quantified by immunofluorescence. Graph shows mean ± SEM from independent experiments with three different donors.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.005](10.7554/eLife.24437.005)

[Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} shows that PMA (**B**), A23187 (**C**) and nigericin (**D**) produced NETs with similar kinetics over a 3--4 hr time course. *C. albicans* (**E**) and GBS (**F**) induced a slower rate of NETosis and non-stimulated cells remained NET free for the duration of the experiment.

[Videos 1](#media1){ref-type="other"}--[6](#media6){ref-type="other"} also visualise the induction of NETosis in response to the aforementioned stimuli over a 6 hr time course. All stimuli resulted in the release of extracellular DNA; however, the temporal order of nucleus decondensation and plasma membrane rupture was varied.Video 1.No NETosis in non-stimulated primary neutrophilsPrimary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green (green) and imaged for 6 hr using a Leica SP8 AOBS confocal microscope. Video is representative of three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.006](10.7554/eLife.24437.006)10.7554/eLife.24437.006Video 2.PMA induced NETosis in primary neutrophilsPrimary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green (green), stimulated with 50 nM PMA and imaged for 6 hr using a Leica SP8 AOBS confocal microscope. The appearance of the green colour indicated NETosis. Video is representative of three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.007](10.7554/eLife.24437.007)10.7554/eLife.24437.007Video 3.A23187 induced NETosis in primary neutrophilsPrimary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green (green), stimulated with 5 µM A23187 and imaged for 6 hr using a Leica SP8 AOBS confocal microscope. The appearance of the green colour indicated NETosis. Video is representative of three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.008](10.7554/eLife.24437.008)10.7554/eLife.24437.008Video 4.Nigericin induced NETosis in primary neutrophilsPrimary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green (green), stimulated with 15 µM nigericin and imaged for 6 hr using a Leica SP8 AOBS confocal microscope. The appearance of the green colour indicated NETosis. Video is representative of three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.009](10.7554/eLife.24437.009)10.7554/eLife.24437.009Video 5.*C. albicans *induced NETosis in primary neutrophils.Primary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green (green), stimulated with MOI 5 *C. albicans* and imaged for 6 hr using a Leica SP8 AOBS confocal microscope. The appearance of the green colour indicated NETosis. Video is representative of three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.010](10.7554/eLife.24437.010)10.7554/eLife.24437.010Video 6.GBS induced NETosis in primary neutrophils.Primary neutrophils were stained with Draq5 (blue) and cell impermeable Sytox Green (green), stimulated with MOI 10 GBS and imaged for 6 hr using a Leica SP8 AOBS confocal microscope. The appearance of the green colour indicated NETosis. Video is representative of three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.011](10.7554/eLife.24437.011)10.7554/eLife.24437.011

PKC is required for PMA, *C. albicans* and GBS induced NETosis. Only PMA and nigericin require calcium to make NETs {#s2-2}
-------------------------------------------------------------------------------------------------------------------

PMA is a direct protein kinase C (PKC) activator which, in turn, leads to calcium fluxes within the cell and both of these processes are required for PMA-induced NETosis ([@bib21]; [@bib14]). As anticipated, PMA-induced NET formation was blocked by the PKC inhibitor Gö6976 ([Figure 2A](#fig2){ref-type="fig"}) ([@bib20]). *C. albicans* and GBS NET induction was also blocked by the PKC inhibitor, albeit to a lesser degree ([Figure 2C](#fig2){ref-type="fig"}). The two ionophores, conversely, did not require PKC ([Figure 2B](#fig2){ref-type="fig"}).10.7554/eLife.24437.012Figure 2.Differential requirements for PKC and calcium and a lack of requirement of transcription for NET induction by the stimuli of interest.(**A--C**) NETosis rate in PKC inhibited neutrophils. Primary neutrophils were pre-treated with the PKC inhibitor Gö6976 (1 µM) for 30 min and stimulated with (**A**) PMA, (**B**) A23187 or nigericin, and (**C**) *C. albicans* or GBS for 2.5--4 hr and analysed for NET production by immunofluorescence. (**D--F**) NETosis rate in neutrophils pre-treated with the calcium chelator BAPTA-AM (10 µM) for 30 min and stimulated with (**D**) PMA, (**E**) A23187 or nigericin and (**F**) *C. albicans* or GBS for 2.5--4 hr and analysed for NET production by immunofluorescence. (**G--I**) NETosis rate in neutrophils pre-treated with actinomycin D (1 µg/ml) for 30 min and stimulated with (**G**) PMA, (**H**) A23187 or nigericin and (**I**) *C. albicans* or GBS for 2.5--4 hr and then analysed for NET production by immunofluorescence. Graphs show mean ± SEM from three independent experiments. \*p\<0.05, NS = not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.012](10.7554/eLife.24437.012)10.7554/eLife.24437.013Figure 2---source data 1.This data is the mean values of three independent NETosis assays in response to the five stimuli of interest in the presence of the PKC inhibitor Gö6976 ([Figure 2A--C](#fig2){ref-type="fig"}), the calcium chelator BAPTA-AM ([Figure 2D--F](#fig2){ref-type="fig"}) and actinomycin D ([Figure 2G--I](#fig2){ref-type="fig"}) and was used to generate the histograms in [Figure 2](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.013](10.7554/eLife.24437.013)

PMA ([Figure 2D](#fig2){ref-type="fig"}) and nigericin ([Figure 2E](#fig2){ref-type="fig"}), induced NETosis was impaired by the calcium chelator BAPTA-AM. This chelator reduced NET formation only slightly in response to A23187 ([Figure 2E](#fig2){ref-type="fig"}). Early work on neutrophil signalling revealed that ionomycin can induce a massive influx of calcium into the neutrophil, reaching a concentration greater than 1 µM ([@bib18]). This abundance of intracellular calcium may have overwhelmed the ability of the BAPTA-AM to chelate the calcium at the concentration used. Pre-treatment of the neutrophils with higher concentrations of the calcium chelator resulted in spontaneous NET formation (data not shown) therefore making the A23187 calcium requirements difficult to assess. A previous study demonstrated a role for calcium in NETosis, however, suggesting that A23187 does in fact require the calcium flux it induces to produce NETs ([@bib21]). Notably, calcium chelation did not impair NETosis in response to *C. albicans* or GBS ([Figure 2F](#fig2){ref-type="fig"}).

Finally, as previously shown for PMA and *C. albicans*, A23187, nigericin and GBS NET induction is independent of transcription ([Figure 2G--I](#fig2){ref-type="fig"}) ([@bib47]).

Differential ROS requirements of NETs {#s2-3}
-------------------------------------

Generation of reactive oxygen species (ROS) is a hallmark of PMA-induced NETosis. [Figure 3A](#fig3){ref-type="fig"} confirms that PMA induced a ROS burst in primary human neutrophils, peaking after 20 min of stimulation. This ROS burst was largely abolished by pre-treating the neutrophils with the ROS scavenger pyrocatechol. A23187 ([Figure 3B](#fig3){ref-type="fig"}) also induced a ROS burst, although with slower kinetics than PMA, peaking around 80 min post stimulation. Pyrocatechol also prevented this ROS burst. In contrast, nigericin did not induce any ROS production ([Figure 3B](#fig3){ref-type="fig"}). Opsonized *C. albicans* generated ROS ([Figure 3C](#fig3){ref-type="fig"}) peaked, like PMA 20 min after activation. GBS-induced ROS production to similar levels but with slower kinetics. ROS release by both microbes was abrogated by pyrocatechol. PMA, A23187, *C. albicans* and GBS induced ROS returned to basal levels 2 hr post-stimulation.10.7554/eLife.24437.014Figure 3.Diverse stimuli have different ROS requirements for NETosis.ROS production by neutrophils (**A--C**). ROS production was measured over a 2-hr time course in the presence or absence of the ROS scavenger pyrocatechol (pyro, 30 µM) in response to (**A**) PMA, (**B**) A23187 or nigericin and (**C**) *C. albicans* or GBS stimulation. Shown is a representative of three independent experiments. (**D--F**) NETosis rate of neutrophils pre-treated for 30 min with pyrocatechol or (**G--I**) NETosis rate of healthy control neutrophils and CGD patients stimulated with (D and G) PMA, (E and H) A23187 or nigericin and (F and I) *C. albicans* or GBS. (**A--C**) Graphs show mean ± SD from a representative of three independent experiments. (**D--F**) Graphs shows mean ± SEM from three independent experiments. (**G--I**) Graphs show mean ± SEM from five to seven independent experiments using neutrophils from five independent CGD patients (each represented by a red circle). \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, NS = not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.014](10.7554/eLife.24437.014)10.7554/eLife.24437.015Figure 3---source data 1.This data is the mean values of three independent NETosis assays in response to the five stimuli of interest in the presence of the ROS scavenger pyrocatechol and was used to calculate the histograms in [Figure 3D--F](#fig3){ref-type="fig"}.This data also shows the means from seven independent experiments with CGD patient neutrophils and was used to generate the histograms in [Figure 3G--I](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.015](10.7554/eLife.24437.015)10.7554/eLife.24437.016Figure 3---figure supplement 1.No ROS production in CGD patient neutrophils, S. aureus requires ROS for NET production and *C. albicans* produces ROS.(**A**) ROS production by CGD neutrophils. Neutrophils from a healthy control donor and a CGD patient were examined for the production of ROS in response to PMA stimulation over a 2-hr time course. Graph shows mean ± SD from a representative of five independent ROS assays carried out with CGD patient neutrophils. (**B**) CGD patient neutrophils are impaired for *S. aureus-*induced NETosis. Healthy and CGD patient neutrophils were stimulated with *S. aureus* at a MOI of 20 for 4 hr and NETosis was examined as previously described. Graph shows mean ± SEM from three independent experiments. (**C**) *C. albicans* produces ROS. *C. albicans-*induced ROS was measured over a 3-hr time course in the presence or absence of either neutrophils (PMN) or pyrocatechol (pyro). Graph shows mean ± SD from a representative of three independent experiments. (**D**) NETosis in response to *C. albicans* utilises ROS generated from *C. albicans*. Healthy neutrophils or *C. albicans* were pre-treated with pyrocatechol for 30 mins. Cells were then stimulated with *C. albicans* at a MOI of 5 for 3 hr and NETosis was examined as previously described. Graph shows mean ± SEM from three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.016](10.7554/eLife.24437.016)

To test whether ROS were required for NETosis, we pre-incubated neutrophils with pyrocatechol before stimulation. As expected, ROS was absolutely required for PMA-induced NETosis ([Figure 3D](#fig3){ref-type="fig"}). Conversely, pyrocatechol did not affect the level of NETosis in response to A23187 or nigericin ([Figure 3E](#fig3){ref-type="fig"}). Interestingly, *C. albicans*-induced NETosis was impaired in the presence of the ROS scavenger, but GBS-induced NETosis was not ([Figure 3F](#fig3){ref-type="fig"}).

To confirm the ROS requirements for NETosis we isolated neutrophils from five patients with chronic granulomatous disease (CGD, mutations outlined in [Table 1](#tbl1){ref-type="table"}). As expected, the neutrophils from these patients were deficient in ROS production ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). As previously described ([@bib14]), CGD patient neutrophils did not undergo NETosis in response to PMA ([Figure 3G](#fig3){ref-type="fig"}) and were also significantly impaired in NET production in the presence of *S. aureus* ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}).10.7554/eLife.24437.017Table 1.CGD patient donors. Nomenclature for genotypes is according to den Dunnen and Antonarakis ([@bib9]).**DOI:** [http://dx.doi.org/10.7554/eLife.24437.017](10.7554/eLife.24437.017)DonorAgeNucleotide changeMutationAmino acid changeResidual activity 124CYBB c.742dupAinsertionp.Ile248AsnfsX36No 225CYBB c.868C \> Tnonsensep.Arg290XNo 318CYBB c.1421T \> Gmissensep.Leu474ArgNo 426CYBB c.868C \> Tnonsensep.Arg290XNo 529CYBA c.371C \> Tmissensep.Ala124ValYes

Notably, and confirming our data with the ROS scavenger, neither A23187 nor nigericin required ROS to generate NETs ([Figure 3H](#fig3){ref-type="fig"}). Intriguingly, and in contrast to data obtained with the ROS scavenger, there was no significant difference in the levels of NETosis comparing healthy vs. CGD patient neutrophils in response to *C. albicans*. This discrepancy was explained by the fact that *C. albicans* can induce a ROS burst itself in the absence of neutrophils and this was inhibited in the presence of the ROS scavenger pyrocatechol ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). Indeed, we confirmed that *C. albicans* produces sufficient ROS to allow NETosis. We pre-incubated the fungus with pyrocatechol ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}) and showed that scavenging *C. albicans-*derived ROS also inhibited NET production. Moreover, by inhibiting ROS in both the neutrophils and the fungus NETosis was inhibited to a greater extent. Thus, the amount of ROS produced by the *C. albicans* was sufficient to allow NETs induction in CGD neutrophils. The amount of NETs were, however, decreased in CGD neutrophils infected with GBS ([Figure 3I](#fig3){ref-type="fig"}) when compared with cells isolated from healthy donors.

Overall, these data show that ROS generated by the NADPH oxidase, while absolutely essential for PMA-induced NETosis, are not necessary for NET production in response to both ionophores and only partially required for *C. albicans* and GBS-induced NETosis.

Differential myeloperoxidase requirements of NETs {#s2-4}
-------------------------------------------------

We explored whether myeloperoxidase (MPO) is also differentially required by the different stimuli. Aminobenzoic acid hydrazide (ABAH) is a potent and irreversible small molecule inhibitor of MPO. Pre-treatment of neutrophils with ABAH did not induce spontaneous NETosis and, as anticipated, significantly decreased PMA-induced NET formation ([Figure 4A](#fig4){ref-type="fig"}). This was confirmed with neutrophils isolated from a MPO-deficient patient stimulated with PMA ([Figure 4D](#fig4){ref-type="fig"}). Similar to the lack of ROS requirement in NETosis in response to ionophores, the MPO inhibitor did not affect NET production by A23187 or nigericin ([Figure 4B](#fig4){ref-type="fig"}) and neutrophils from a MPO-deficient individual underwent NETosis in response to both stimuli ([Figure 4E](#fig4){ref-type="fig"}). Interestingly, and contrary to the subtle role of ROS in NETosis induction, NETs induced by *C. albicans* or GBS stimulation required MPO ([Figure 4C and F](#fig4){ref-type="fig"}).10.7554/eLife.24437.018Figure 4.Myeloperoxidase is essential for PMA, *C. albicans* and GBS-induced NETosis but not for A23187 and nigericin-induced NET formation.(**A--F**) NETosis rate in response to (A and D) PMA, (B and E) A23187 or nigericin and (C and F) *C. albicans* or GBS. (**A--C**) Primary neutrophils were pre-treated for 30 min with 500 µM ABAH or a DMSO control, stimulated as indicated for 2.5--4 hr and analysed for NET production by immunofluorescence. Graphs show mean ± SEM from three independent experiments. (**D--F**) Healthy control neutrophils and neutrophils from a MPO-deficient patient were stimulated as outlined above. Graphs show mean ± SD from a representative of two independent experiments from a single MPO-deficient donor. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, NS = not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.018](10.7554/eLife.24437.018)10.7554/eLife.24437.019Figure 4---source data 1.This data is the mean of three independent NETosis assays in response to the five stimuli of interest in the presence of the MPO inhibitor ABAH and was used to generate the histograms in [Figure 4A--C](#fig4){ref-type="fig"}.This data also shows the raw data used to calculate the mean of a representative experiment using MPO-deficient neutrophils used to generate the histograms in [Figure 4D--F](#fig4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.019](10.7554/eLife.24437.019)

Downstream of ROS and MPO, neutrophil elastase is differentially required for NETosis {#s2-5}
-------------------------------------------------------------------------------------

Pre-treatment of healthy neutrophils with a highly specific small molecule NE inhibitor ([@bib37]) did not result in spontaneous NETosis and significantly impaired PMA, *C. albicans* and GBS induced NETs ([Figure 5A and C](#fig5){ref-type="fig"}). NETosis in response to A23187 and nigericin did not require NE ([Figure 5B](#fig5){ref-type="fig"}). These data show that ionophores do not require the molecules relevant in other forms of NET induction such as ROS, MPO and NE.10.7554/eLife.24437.020Figure 5.Neutrophil elastase is required for PMA, *C. albicans* and GBS-induced NETosis but not for A23187 or nigericin NET production.(**A--C**) NETosis rate of neutrophils during NE inhibition. Primary neutrophils were pre-treated for 30 min with a neutrophil elastase inhibitor (GW311616A, 20 µM) or a DMSO control and stimulated for 2.5--4 hr with (**A**) PMA, (**B**) A23187 or nigericin and (**C**) *C. albicans* or GBS and analysed for NET production by immunofluorescence. Graphs show mean ± SEM from three independent experiments. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, NS = not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.020](10.7554/eLife.24437.020)10.7554/eLife.24437.021Figure 5---source data 1.This data is the mean of three independent NETosis assays in response to the five stimuli of interest in the presence of a NE inhibitor and was used to generate the histograms in [Figure 5A--C](#fig5){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.021](10.7554/eLife.24437.021)

Histone citrullination occurs but is not required for NET induction {#s2-6}
-------------------------------------------------------------------

Stimulation of neutrophils with A23187, nigericin, *C. albicans* and GBS, but not PMA, resulted in Histone H3 citrullination (cit-H3) within 90 min as shown by Western blot analysis, ([Figure 6A](#fig6){ref-type="fig"}) confirming previous publications for both PMA and the calcium ionophore ([@bib41]). The citrullination data were confirmed by quantifying NETosis and the number of cit-H3-positive cells by immunofluorescence. Very few of the PMA induced NETs ([Figure 6B](#fig6){ref-type="fig"}) stained positively for cit-H3. Each of the other stimuli induced both NETosis and citrullination to varying levels ([Figure 6C and D](#fig6){ref-type="fig"}), confirming the data seen by Western blot analysis.10.7554/eLife.24437.022Figure 6.Citrullination of histone H3 occurs during NETosis but is not required for NET induction.(**A--D**) Histone H3 was citrullinated during NETosis in response to all stimuli bar PMA. (**A**) Primary neutrophils were stimulated for 90 min with PMA, A23187, nigericin, *C. albicans* or GBS, lysed and assayed for the presence of citrullinated histone H3 and GAPDH by SDS-PAGE electrophoresis and Western immunoblotting. (**B--D**) NETosis rate and percentage of citrullinated cells in response to (**B**) PMA, (**C**) A23187 or nigericin and (**D**) *C. albicans* or GBS. Graphs show mean ± SD from a representative of two independent experiments. (**E--G**) NETosis rate in neutrophils pre-treated with the PAD inhibitor Cl-amidine at 200 µM, BB-Cl-amidine at 10 µM, TDFA at 200 µM, or DMSO as control and stimulated with (**E**) PMA, (**F**) A23187 or nigericin and (**G**) *C. albicans* or GBS and analysed for NET production by immunofluorescence. Graphs show mean ± SEM from 10 independent experiments. \*p\<0.05, NS = not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.022](10.7554/eLife.24437.022)10.7554/eLife.24437.023Figure 6---source data 1.This data is the mean of ten independent NETosis assays in response to the five stimuli of interest in the presence of the PAD inhibitors and was used to generate the histograms in [Figure 6](#fig6){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.023](10.7554/eLife.24437.023)10.7554/eLife.24437.024Figure 6---figure supplement 1.PAD inhibitors reduce histone H3 citrullination.Neutrophils were pre-treated with (**A**) 200 µM Cl-amidine, (**B**) 10 µM BB-Cl-amidine or (**C**) 200 µM TDFA, stimulated with A23187, *C. albicans* or GBS for 3--4 hr, fixed, stained with an antibody against citrullinated histone H3 and hoechst and analysed for percentage of cells citrullinated on histone H3 by immunofluorescence. Graphs show mean ± SEM from three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.024](10.7554/eLife.24437.024)10.7554/eLife.24437.025Figure 6---figure supplement 2.PAD inhibitors do not prevent NETosis.(**A--J**) Neutrophils were pre-treated with Cl-amidine at 200 µM (light grey bars), BB-Cl-amidine at 10 µM (dark grey bars), TDFA (black bars) at 200 µM, or DMSO as control (white bars), stimulated with PMA, A23187, nigericin, *C. albicans* or GBS for 2.5--4 hr and analysed for NET production by immunofluorescence. Graphs show mean ± SD from 10 independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.025](10.7554/eLife.24437.025)

We next explored if citrullination was required for NET formation. Neutrophils were pre-treated with three inhibitors of PAD proteins: Cl-amidine and BB-Cl-amidine, both of which inhibit PAD2 and PAD4, and Thr-Asp-F-amidine (TDFA), a potent specific PAD4 inhibitor. Treating neutrophils with Cl-amidine, BB-Cl-amidine or TDFA did not induce NETosis spontaneously ([Figure 6E](#fig6){ref-type="fig"}). PMA induced NETosis was not affected by these inhibitors, consistent with the data obtained with GSK199, another PAD4-selective inhibitor ([Figure 6E](#fig6){ref-type="fig"}) ([@bib34]). Importantly, in response to A23187 or nigericin stimulation, NETosis remained intact after incubation with the three inhibitors ([Figure 6F](#fig6){ref-type="fig"}). Similarly, these inhibitors did not affect *C. albicans* or GBS-induced NETosis ([Figure 6G](#fig6){ref-type="fig"}). These data are the combination of 10 independent experiments with different donors. Each individual experiment is shown in [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}. The three inhibitors reduced citrullination in response to A23187, *C. albicans* and GBS, confirming that these inhibitors were active ([Figure 6---figure supplement 1A--C](#fig6s1){ref-type="fig"}).

These data show that histone H3 citrullination occurs during the course of NETosis in response to A23187, nigericin, *C. albicans* and GBS but not PMA-induced NETs. Moreover, the inhibitor assays demonstrate that PAD2 and PAD4 are not required for NETosis.

All stimuli induce NETs that are proteolytically active, kill bacteria and are composed primarily of nuclear DNA {#s2-7}
----------------------------------------------------------------------------------------------------------------

We next examined the properties of the NETs generated by the different stimuli. We began by examining the proteolytic activity of the NETs. As previously shown for PMA ([@bib42]), the induction of NETosis with all five stimuli resulted in the degradation of histone H3 at both 90 and 180 min ([Figure 7A](#fig7){ref-type="fig"}). Stimulation with PMA and nigericin resulted in strong degradation at the 90 min time point and a total loss of the full length histone H3 at 180 min. Conversely, A23187, *C. albicans* and GBS stimulation led to less degradation overall. This was further confirmed by assaying the degradation of FITC-labelled casein in the presence of NETs isolated from healthy neutrophils treated with the five stimuli ([Figure 7B](#fig7){ref-type="fig"}). NETs from all five stimuli were capable of degrading FITC-labelling casein to a similar level indicating they are proteolytically active. The supernatant of non-stimulated neutrophils was used to determine the background level of degradation and a known concentration of trypsin was added as a positive control.10.7554/eLife.24437.026Figure 7.NETs are proteolytically active, kill bacteria and are mainly composed of chromosomal DNA.(**A**) NETosis leads to histone H3 degradation. Primary neutrophils were stimulated for 90 and 180 min with PMA, A23187, nigericin, *C. albicans* or GBS, lysed and assayed for the presence of histone H3 and GAPDH by SDS-PAGE electrophoresis and Western immunoblotting. Shown is a representative of three independent experiments. (**B**) Isolated NETs are proteolytically active. NETosis was induced for 4 hr, NETs were isolated after treatment with *Alu*I for 20 min, the DNA content was determined and 200 ng/ml DNA was tested for its proteolytic activity using the Pierce Fluorescent Protease Assay Kit according the manufacturer's instructions. 100 µl of non-stimulated neutrophil supernatant was used to determine the background activity and 125 ng/ml trypsin was added as a positive control. (**C**) NETs can kill *E. coli*. Neutrophils were stimulated to produce NETs for 4 hr. Phagocytosis was inhibited by the addition of Cytochalasin D and *E. coli* at a MOI of 1 were added in the presence or absence of 50 U/ml DNase 1. After 1 hr the cells, NETs and *E. coli* were collected (selected samples were sonicated), serially diluted, plated on tetracycline-resistant agar plates and incubated for 24 hr at 37°C followed by CFU counts to determine killing. (**D**) NETs are primarily composed of chromosomal DNA. 4 hr post NET induction the NETs were isolated by MNase treatment, followed by proteinase K treatment. NET DNA was isolated by phenol-chloroform extraction and the ratio of *S18* to *S16* DNA was analysed by real-time PCR. Graphs show mean ± SEM from three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.026](10.7554/eLife.24437.026)

Next we tested the ability of the NETs to kill *E.coli*. Healthy neutrophils were treated for 4 hr with the stimuli to induce NETosis, phagocytosis was blocked with the addition of Cytochalasin D and *E.coli* were added for 1 hr in the presence or absence of DNase 1 (to degrade the NETs). NETs produced by all five stimuli were capable of limited killing that was blocked in the presence of DNase 1 ([Figure 7C](#fig7){ref-type="fig"}). The NETs were sonicated post *E.coli* incubation to release bacteria potentially trapped in clumps and skewing the killing counts. This did not affect the bacterial counts indicating that the NETs were in fact killing the bacteria.

We also examined the NETs for the presence of mitochondrial DNA as this is seen in response to autoimmune stimuli such as ribonucleoprotein immune complexes ([@bib35]). NETs produced in response to PMA, nigericin, *C. albicans* and GBS contained around 10% mitochondrial DNA and A23187 NETs contained around 25% ([Figure 7D](#fig7){ref-type="fig"}). This is in line with previous work demonstrating that NETs are mainly generated from chromosomal DNA ([@bib35]).

Taken together this data revealed that NETs produced in response to all stimuli tested can degrade proteins, kill bacteria and mostly contain nuclear DNA.

NETosis is distinct from other forms of cell death {#s2-8}
--------------------------------------------------

To conclude, we compared NETosis, apoptosis, necrosis and necroptosis in neutrophils. We treated neutrophils with a caspase-3 inhibitor to block apoptosis or necrostatin to prevent necroptosis and measured NET formation revealing that NETosis is not affected by either of these inhibitors ([Figure 8A--C](#fig8){ref-type="fig"}).10.7554/eLife.24437.027Figure 8.NETosis is a unique form of cell death different from apoptosis, necrosis and necroptosis.(**A--C**) NETosis occurs in the presence of apoptosis and necroptosis inhibitors. Primary human neutrophils were pre-treated for 30 min with 20 µM caspase-3 inhibitor or 30 µM necrostatin or a DMSO control and stimulated with (**A**) PMA, (**B**) A23187 or nigericin and (**C**) *C. albicans* or GBS for 2.5--4 hr and analysed for NET production by immunofluorescence. Graphs show mean ± SEM from three independent experiments. (**D**) NETosis rate in the presence of the apoptosis inducer staurosporine. Primary neutrophils were stimulated for 2--6 hr with staurosporine (500 nM) or PMA and analysed for NET induction by immunofluorescence. Graphs show mean ± SEM from three independent experiments. (**E**) NETosis rate in response to necrosis or necroptosis inducers. Primary neutrophils were stimulated with α-hemolysin (25 µg/ml) to induce necrosis or with TNF-α (50 ng/ml), Z-VAD-FMK (50 µM) and a SMAC mimetic (100 nM) or cycloheximide (25 µg/ml) to induce necroptosis for 6 hr and analysed for NET production by immunofluorescence. Graphs show mean ± SEM from three independent experiments. NS = not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.027](10.7554/eLife.24437.027)10.7554/eLife.24437.028Figure 8---source data 1.This data is the mean of three independent NETosis assays in response to the five stimuli of interest in the presence of necrostatin or caspase 3 inhibitor and was used to generate the histograms in [Figure 8A--C](#fig8){ref-type="fig"}.This data also shows the mean of three independent NETosis experiments in response to staurosporine ([Figure 8D](#fig8){ref-type="fig"}), hemolysin (to induce necrosis), TNF-α, Z-VAD-FMK and a SMAC mimetic or cycloheximide (to induce necroptosis) and was used to generate [Figure 8E](#fig8){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.028](10.7554/eLife.24437.028)10.7554/eLife.24437.029Figure 8---figure supplement 1.Apoptosis, necrosis and necroptosis can be induced in primary neutrophils, NETosis results in LDH release.(**A**) Staurosporine induced caspase-3 cleavage in neutrophils. Primary neutrophils were pre-treated with a caspase-3 inhibitor for 30 mins, stimulated with staurosporine for 3 hr; cell lysates were generated and assayed for the presence of cleaved caspase-3 and β-actin by SDS-PAGE electrophoresis and Western immunoblotting. Data shown is a representative of three independent experiments. (**B**) Staurosporine does not induce LDH release. Neutrophils were stimulated with staurosporine for 21 hr and LDH release was measured as per the manufacturer's instructions. (**C**) Neutrophils were stimulated for 21 hr with α-hemolysin and LDH release was measured. (**D**) Neutrophils were pre-treated with a necrostatin inhibitor for 30 min and stimulated with TNF-α, Z-VAD-FMK and a SMAC mimetic or cycloheximide (CHX) for 21 hr and LDH release was measured. (**C--D**) Graphs show mean ± SD from a representative of two independent experiments. (**E**) LDH is released in NETosis. Neutrophils were treated with the indicated stimuli for 4 hr and LDH release was measured. Graph shows mean ± SEM from three independent experiments. Treatment of neutrophils with triton-X100 was used to normalise the data with triton treatment set to 100% LDH release.**DOI:** [http://dx.doi.org/10.7554/eLife.24437.029](10.7554/eLife.24437.029)

Importantly, the apoptosis inducer staurosporine did not induce NET formation even after 6 hr incubation ([Figure 8D](#fig8){ref-type="fig"}). As a control, we showed that staurosporine-induced apoptosis in neutrophils as demonstrated by the presence of cleaved caspase-3. This cleavage was blocked by a caspase-3 inhibitor ([Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}). These data were confirmed with the pan-caspase inhibitor Z-VAD-FMK (data not shown). As expected, staurosporine did not induce LDH release ([Figure 8---figure supplement 1B](#fig8s1){ref-type="fig"}).

Finally, we induced necrosis with α-hemolysin from *Staphylococcus aureus* or necroptosis with a cocktail of TNF-α, Z-VAD-FMK and a SMAC mimetic or cycloheximide (CHX) and measured NETosis. Neither necrosis nor necroptosis activation induced NETosis beyond the level seen in the non-stimulated cells over a 6-hr time course ([Figure 8E](#fig8){ref-type="fig"}). LDH assays confirmed that α-hemolysin and the necroptosis cocktail-induced cell death ([Figure 8---figure supplement 1C and D](#fig8s1){ref-type="fig"}). As a control, we verified that necrostatin blocked cell death due to necroptosis ([Figure 8---figure supplement 1D](#fig8s1){ref-type="fig"}).

Lastly, we investigated whether LDH release occurs during NETosis. [Figure 8---figure supplement 1E](#fig8s1){ref-type="fig"} showed that PMA, nigericin, *C. albicans* and GBS stimulation resulted in LDH release greater than non-stimulated cells at 4 hr. A23187 treatment also resulted in LDH release but to a lesser extent.

In conclusion, these data show that NETosis is a unique form of cell death that does not utilise components of the pathways associated with apoptosis, necrosis or necroptosis.

Discussion {#s3}
==========

Recent work focusing on the various stimuli that lead to NETosis has yielded contradictory results in response to the same stimuli. These discrepancies may arise from technical issues such as differences in neutrophil isolation protocols, the culture of neutrophils in different types of cell culture media and the concentration of stimuli used. With this in mind, we aimed here to confirm that our stimuli of interest generate NETs by use of the benchmark for NETosis analysis: quantifiable analysis along with fixed cell imaging and live cell videos.

Using these methods, we demonstrate here that NETs can be robustly induced by a broad range of stimuli, including PMA, the ionophores A23187 and nigericin and the more physiologically relevant stimuli *C. albicans* and GBS. Using neutrophils isolated from healthy donors and patients as well as small molecule inhibitors, we show that NET formation occurs through different signalling pathways. The NETs generated by all five stimuli were proteolytically active, kill bacteria and composed mainly of chromosomal DNA. We also show that NETosis is distinct from other cell death pathways such as apoptosis, necrosis and necroptosis.

The data shown here demonstrates that PMA-induced NETs require PKC, calcium, ROS, MPO and NE. Conversely, Histone H3 is not citrullinated upon stimulation with PMA and transcription plays no role as has been previously shown ([@bib47]).

Clarifying the mechanisms of NET formation in response to *C. albicans* and GBS proved to be challenging, perhaps due to the need to culture fresh microbes for each experiment. Similar to PMA both microbes require PKC, MPO and NE and do not require transcriptional activation for NET formation. However, both microbes induce the citrullination of histone H3. Despite this PAD2/PAD4 activity is not required for NETosis in response to the microbes.

The role of ROS is less conclusive as there is a discrepancy between comparing healthy neutrophils treated with ROS scavengers and cells isolated from CGD patients. Indeed, *C. albicans* induces significantly less NETs when ROS were pharmacologically abrogated in neutrophils from healthy donors. In contrast, neutrophils from CGD patients produced similar amounts of NETs as those isolated from healthy controls. This suggests that the ROS used by *C. albicans* do not originate from the NADPH oxidase complex. We show here that indeed *C. albicans* itself can produce ROS thus circumventing the ROS requirements of the neutrophil by producing sufficient levels of ROS to allow CGD neutrophils to form NETs. These results are very much in line with the clinical phenotype in which patients with CGD suffer more frequently from invasive infections with *A. fumigatus* than with *C. albicans* ([@bib24]). Recently, a study demonstrated that CGD patient neutrophils produce significantly less NETs in response to *A. fumigatus* than healthy neutrophils further adding to our evidence that neutrophils from CGD patients react diversely to fungal infections ([@bib17]).

The role of ROS in GBS-induced NETosis is confounded by the ability of healthy neutrophils to produce normal levels of NETs in the presence of the ROS scavenger but a significantly reduced level of NETosis in the CGD patient neutrophils. The CGD patient data suggest a requirement for NAPDH oxidase-dependent ROS for GBS induced NETs that is perhaps not revealed by the ROS scavenger. As seen in [Figure 3C](#fig3){ref-type="fig"}, there was some residual ROS production in response to GBS in the presence of the ROS scavenger. This level of ROS may be sufficient for the GBS to induce NETosis in a manner similar to *C. albicans* in which the amount of ROS produced by the fungus allows NETosis to occur in the CGD patient neutrophils. It must also be noted that although the ability of GBS to induce NETosis was significantly reduced in the CGD patients, a high level of NETosis still occurred in these cells. Taken together, these data suggest that while PMA absolutely relies on NADPH oxidase derived ROS for NETosis *C. albicans* and GBS can circumvent this need to some degree. This could be due to the ability of the microbes to generate ROS themselves that is then hijacked by the neutrophil to generate NETs in the absence of a self-source of ROS.

This is in contrast with NETosis induction by *S. aureus* which was dependent on the ability of the neutrophils to generate ROS as outlined in the original study on NETosis in CGD patient neutrophils ([@bib14]). This suggests that NETosis induced by physiologically relevant stimuli is also very diverse in the signalling pathways utilised and hence challenging to clarify. Indeed, *Leishmania amazonensis* can induce NETosis in the absence of ROS production ([@bib45]; [@bib11]).

The role of ROS production in the generation of NETs is further confounded by recent work demonstrating that the mitochondria can also be a source of ROS in NETosis in response to calcium ionophores ([@bib12]) or ribonucleoprotein-containing immune complexes (RNP ICs) ([@bib35]). These data demonstrate that outside of the NADPH-oxidase complex the neutrophil has other ROS sources that are sufficient to induce NETosis.

Conversely, activation with the ionophores A23187 and nigericin does not require PKC, ROS, MPO or NE or transcriptional activation and calcium only has a limited role. Histone H3 is citrullinated upon activation by these stimuli; however, pre-treatment with PAD inhibitors does not affect the ability of the neutrophils to make NETs. This suggests that citrullination (of histone H3 at least) is a consequence of NETosis, and that PAD4 is not required for NET formation. Ionophore and PMA-induced NETosis appears to be distinct, at least in the few components of the signal transduction cascade already described.

A23187 is a calcium ionophore that causes a massive influx of calcium and nigericin stimulates potassium effluxes in cells which also results in the influx of calcium demonstrating the similarity between the ionophores in their mechanism of NET induction ([@bib51]). This flooding of the neutrophil with calcium ions could thus result in perturbation of the membrane potential and cell death that ultimately releases NETs. While the method to initiate NET induction by the ionophores is very different to that seen in response to PMA, the end product appears to be similar.

Auto-antibodies directed against citrullinated proteins are commonly found in the serum of rheumatoid arthritis patients ([@bib49]) and as such elucidating the origin of these modified proteins is of great therapeutic interest. Recent research suggests that PAD enzymes, in particular PAD4, are associated with the induction of NETosis. Consistent with this, PAD4-deficient mice do not generate NETs in response to a calcium ionophore which is in direct contrast to the data presented here ([@bib39]). However, the readout for NETosis used in this study was the presence of extracellular DNA decorated with citrullinated histone H3. Since deficiency in PAD4 results in no citrullination of histones this study lacks a readout in the PAD4-deficient cells that would confirm the presence or absence of NETs such as staining with antibodies against NE or MPO on the extracellular DNA. It is also important to note that these experiments were carried out using murine neutrophils which may not behave similarly to human cells ([@bib3]). Importantly, studies examining the requirements of the PAD enzymes in human NETosis, using the same PAD inhibitors, also demonstrate a very limited inhibition of NETosis in response to a calcium ionophore and *S. aureus* ([@bib26]; [@bib34]). Thus, it appears that while PAD enzymes might be important for murine neutrophils to generate NETs, this effect is not seen in human neutrophils.

One additional discrepancy between our data and published reports is the observation that PAD inhibitors (both selective and pan-PAD) show efficacy in multiple mouse models of SLE and RA ([@bib31]; [@bib19]; [@bib29]). These studies suggest that citrullination is important in disease pathogenesis and as such could affect NET function. We do not understand how NETs function as antimicrobials, immune cell activators or in coagulation. It is possible that these NET functions are altered by the citrullination of NETs components. Indeed, the phenotype observed in the PAD4-deficient mice could potentially be attributed to the effectiveness of NETs and not necessarily NET formation.

A recent review highlights the wide range of proteins and pathways required for NETosis in response to a variety of stimuli with emphasis on the questions surrounding the role of citrullination in NETosis ([@bib33]). It states that ionophores and bacterial pore-forming toxins induce a pathway within neutrophils that results in the citrullination of histones but that is distinct from NETosis. They term this form of neutrophil cell death leukotoxic hypercitrullination (LTH) and suggest it is not antimicrobial but a bacterial strategy to kill neutrophils. The data shown here demonstrates that in the presence of the calcium ionophore or nigericin nuclear decondensation occurs and results in the extrusion of DNA, chromatin and peptides from neutrophils, albeit in a different manner to that utilised by PMA, *C. albicans* and GBS. Whether these extruded DNA and proteins are antimicrobial, however, requires further investigation.

The different mechanisms of neutrophil cell death have been studied in detail and as such the data presented here can be included in the body of evidence that NETosis is in fact a distinct cell death mechanism utilised to aid in pathogen killing by neutrophils ([@bib14]; [@bib44], [@bib43]). However, two recent studies on the role of necroptosis in NETs induction present contrasting evidence for and against the requirements of necroptosis ([@bib1]; [@bib10]). Our data strengthens the argument that necroptosis is a separate cell death signalling cascade that is not required by neutrophils to induce NETosis.

Our observations show that there are different paths to NETosis in human cells. The elucidation of these pathways is of importance due to the ancient nature of chromatin release as a form of host defence as has been identified in both the animal and plant kingdoms. Therefore, it is unsurprising that NETosis is induced through a wide range of pathways ([@bib48]).

Consequently, the clarification of these different pathways to NETosis has definite therapeutic relevance. There is a genuine need to identify NET inhibitors to alleviate or prevent many diseases including cystic fibrosis, thrombosis, malaria and sepsis ([@bib28]; [@bib7]). NETs are present in the sputum of cystic fibrosis (CF) patients and contribute to the viscosity of the sputum ([@bib38]). NETs are evident in the thrombus in deep vein thrombosis (DVT) and disease activity is reflective of NET markers in the plasma ([@bib15]). Many autoimmune diseases such as Systemic lupus erythematosus (SLE) and vasculitis also show a very strong NET phenotype with regard the presence of autoantibodies against proteins readily released from neutrophils in the process of NETosis such as anti-dsDNA and anti-neutrophil cytoplasmic autoantibodies ([@bib23]; [@bib30]).

This study will aid in the development of tools to help combat the detrimental effects of NETosis while balancing this with the need for the neutrophils to fulfil their purpose in the presence of a pathogen and induce their unique cell death program.

Materials and methods {#s4}
=====================

Inhibitors {#s4-1}
----------

Gö6976 (PKC, Biozol), BAPTA-AM (Thermo Fisher Scientific), Actinomycin D, GW311616A (NE) and pyrocatechol (Sigma-Aldrich), 4-Aminobenzoic acid hydrazide (ABAH, Cayman chemical), Cl-amidine ([@bib8]), BB-Cl-amidine ([@bib31]), TDFA ([@bib27]), caspase-3 inhibitor and necrostatin (Merck-Millipore).

Donor consent {#s4-2}
-------------

Blood samples were collected according to the Declaration of Helsinki with study participants providing written informed consent. All samples were collected with approval from the ethics committee--Charité --Universitätsmedizin Berlin. Healthy neutrophils were isolated from blood donated anonymously at the Charité Hospital Berlin.

Strains and media {#s4-3}
-----------------

*Candida albicans* clinical isolate SC5314 was cultured overnight at 30°C in YPD media. GBS was grown on a 6% sheep blood agar plate overnight at 37°C, sub-cultured in Todd-Hewitt broth (Sigma-Aldrich) for 2--3 hr until the OD~600nm~ reached 0.5. *Staphylococcus aureus* was prepared as previously described ([@bib14]). *E. coli* XL1-Blue (Stratagene) was cultured overnight at 37°C in LB plus tetracycline. The *C. albicans*, GBS and *S.aureus* were opsonized for 30 min at 37°C with 10% human serum before addition to the neutrophils. This also ensured hyphal growth of the *C. albicans*.

Neutrophil isolation and NET induction {#s4-4}
--------------------------------------

Human neutrophils were isolated by centrifuging heparinized venous blood over Histopaque 1119 (Sigma-Aldrich) and subsequently over a discontinuous Percoll (Amersham Biosciences) gradient as previously described ([@bib14]). Experiments were performed in RPMI-1640 (w/o phenol red) supplemented with 10 mM HEPES and 0.05% human serum albumin. Cells were seeded at 10^5^/well (24-well plate) for NET experiments and stimulated with PMA, staurosporine, cycloheximide (Sigma-Aldrich), A23187 (Santa Cruz Biotechnology Inc.), Nigericin (InvivoGen), *Candida albicans* SC5314 hyphae, GBS, α-hemolysin (generated as previously described \[[@bib50]\]), *Staphylococcus aureus* (prepared as previously described \[[@bib14]\]), TNF-α (Thermo Fisher Scientific), z-VAD-FMK (Enzo) or SMAC mimetic (Birinapant, ChemieTek) for 2--6 hr. Where applicable, cells were pre-treated inhibitors for 30 min before stimulation.

NET staining and quantification {#s4-5}
-------------------------------

Neutrophils seeded on glass coverslips were stained and quantified as previously described ([@bib5]). Briefly, cells were fixed in 2% paraformaldehyde (PFA) post-NET induction, permeabilized on 0.5% Triton-X100, blocked for 30 min in blocking buffer. Neutrophils were then stained with the following primary antibodies: anti-neutrophil elastase (Calbiochem: 481001, RRID:[AB_212213](https://scicrunch.org/resolver/AB_212213)) and antibodies directed against the subnucleosomal complex of Histone 2A, Histone 2B, and chromatin (\[[@bib36]\], generated in house). The secondary antibodies donkey anti-mouse Cy3 (Jackson ImmunoResearch Labs: 715-175-150, RRID:[AB_2340819](https://scicrunch.org/resolver/AB_2340819)) and donkey anti-rabbit Alexa Fluor488 (Life Technologies: A11008, RRID:[AB_143165](https://scicrunch.org/resolver/AB_143165)) were used. Finally, the samples were stained with Hoechst 33342 (Immunochemistry: 639, RRID:[AB_2651135](https://scicrunch.org/resolver/AB_2651135)) and mounted with Mowiol. Image acquisition was c using a Leica DMR upright fluorescence microscope equipped with a Jenoptic B/W digital microscope camera and analysed using ImageJ/FIJI software.

Confocal microscopy {#s4-6}
-------------------

Primary human neutrophils (10^6^) were washed once by centrifugation (300 g, 10 min, RT) in imaging medium (20 mM HEPES, 2.5 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 0.1% Human Serum Albumin, pH 7.4) (Sigma Aldrich) and then resuspended in 4 ml imaging medium containing 2 µM draq5 (Biostatus) and 0.5 µM Sytox Green (Thermo Fischer Scientific). Each well of an eight-well ibidi treat dish (ibidi) was filled with 200 µl of that suspension and cells were allowed to settle down for 30 min at imaging temperature. NETs were induced by PMA, A23187, nigericin, *C. albicans* or GBS at the concentrations outlined above. Imaging was performed with a Leica SP8 AOBS confocal microscope equipped with a motorized stage and temperature-controlled chamber at 36°C. Images (2048\*2048 pixels) were acquired at 0.5% maximal laser intensities every 2 min for each well for a total duration of 6 hr.

ROS assay {#s4-7}
---------

Neutrophils were seeded at concentration of 1 × 10^5^ cells per well in 200 μl RPMI (w/o phenol red) supplemented with 10 mM HEPES, 0.05% human serum albumin, 50 μM luminol and 1.2 units/ml horseradish peroxidase and pre-treated with pyrocatechol for 30 min at 37°C. The cells were then stimulated for 2 hr with the indicated stimuli and luminescence was measured over time in a VICTOR Light luminescence counter from Perkin Elmer.

Western blot {#s4-8}
------------

Neutrophil lysates were generated from 5 × 10^6^ cells 90, 180 min (cit-H3 and H3) or 3 hr (caspase-3) post stimulation by lysis in RIPA buffer (50 mM Tris-HCl Ph 8.0, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mM sodium fluoride, 25 mM sodium pyrophosphate) supplemented with protease inhibitor cocktail (Sigma-Aldrich), 20 µM neutrophil elastase V inhibitor and 20 µM cathepsin G inhibitor (219372, both Calbiochem). Protein lysates were quantified by bicinchoninic acid assay (BCA assay, Pierce) according to manufacturer's instructions. Protein lysates were resolved by sodium dodecyl sulfate--polyacrylamide gel electrophoresis followed by analysis via Western immunoblotting using an anti-citrullinated Histone H3 primary antibody (abcam: ab5103, RRID:[AB_304752](https://scicrunch.org/resolver/AB_304752)), an anti-histone H3 antibody (Active Motif: 39164, discontinued) an anti-cleaved Caspase-3 antibody (9661, RRID:[AB_2341188](https://scicrunch.org/resolver/AB_2341188)), anti-β-actin (5057S, RRID:[AB_10694076](https://scicrunch.org/resolver/AB_10694076)) or anti-GAPDH (all Cell Signaling Technology: 5014S RRID:[AB_10693448](https://scicrunch.org/resolver/AB_10693448)) and anti-rabbit HRP (Jackson ImmunoResearch Labs: 111-035-144, RRID:[AB_2307391](https://scicrunch.org/resolver/AB_2307391)).

Protease activity assay {#s4-9}
-----------------------

NETs were generated as described above using 1.5 × 10^6^ cells/point. The NETs were isolated as previously described ([@bib4]). Briefly, the samples were treated with 4 U/ml *Alu*I, the NETs were collected, their DNA was quantified using the Quant-iT PicoGreen dsDNA Assay Kit (Thermo Fischer Scientific) and the protease activity of 200 ng/ml of NET DNA was quantified using the Pierce Fluorescent Protease Assay kit according to the manufacturer's instructions. 100 µl of non-stimulated neutrophil supernatant was used to calculate background protease activity and 125 ng/ml trypsin was used as a positive control.

Bacterial killing assay {#s4-10}
-----------------------

NETs were generated as described above using 1 × 10^6^ cells/point and stimulated for 4 hr. Bacterial killing was assayed as previously described ([@bib13]). Briefly, once NETosis was induced (visualised by light microscopy), the cells were treated with 10 µg/ml Cytochalasin D (Sigma-Aldrich) for 15 min to block phagocytosis. A subset of samples were treated with DNase 1 at 50 U/ml to degrade the NETs prior to killing. A tetracycline-resistant *E. coli* strain was added to the neutrophils at a MOI of 1 and incubated at 37°C for 1 hr. The cells and *E. coli* were collected, a subset of samples were sonicated to release any trapped bacteria, serially diluted, plated on tetracycline-treated agar plates and incubated at 37°C for 24 hr. Finally CFUs were counted.

Quantitative real-time PCR of mitochondrial and nuclear content of NETs {#s4-11}
-----------------------------------------------------------------------

NETs were generated as described above using 1.5 × 10^6^ cells/point for 4 hr. NETs were released, DNA was isolated and analysed for nuclear (*S18)* versus mitochondrial (*S16*) content by Q-PCR as previously described ([@bib35]).

LDH assay {#s4-12}
---------

Neutrophils were seeded at 1 × 10^5^ cells/well in a 96-well plate and treated for 21 hr with the indicated stimuli. LDH release was quantified from the supernatants using Cytotox 96 Non-Radioactive Cytotoxicity Assay (Promega) according to the manufacturer's instructions.

Statistics {#s4-13}
----------

Data are presented as mean ± SEM unless otherwise noted and were analysed using a two-sided Student t test. All analyses were performed using GraphPad Prism software (Version 6.04). Results were considered significant at p\<0.05 (\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001).
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###### Graphical abstract: The diverse mechanisms of NETosis.

In this study, we investigated whether NETosis occurs through a single signalling pathway or is induced by the five stimuli of interest in a diverse manner. As demonstrated, NETosis in response to *C. albicans* and GBS requires ROS, MPO and NE and induces histone H3 citrullination. This is in comparison to the NETosis seen in response to A23187 and nigericin during which none of the molecules highlighted above are required but citrullination of histone H3 does occur. Finally, we re-confirm that PMA-induced NETosis requires ROS, MPO and NE but does not result in the citrullination of histone H3.
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Summary:

Neutrophil extracellular traps appear to have several functions including defence against some bacterial and fungal pathogens. In the current manuscript, the authors investigated mechanisms involved in the formation of neutrophil extracellular traps. The authors stimulated neutrophils with 5 widely varied stimuli; the mitogen PMA, the ionophores A23187 and nigericin (bacterial toxin), the fungus *Candida albicans* and the gram positive bacteria Group B Streptococcus (GBS). According to their results, PMA, *C. albicans* and GBS use a related pathway for NET induction whereas ionophores require an alternative pathway. Thus, NETosis occurs through several signalling mechanisms, suggesting that extrusion of NETs is important in host defence. The analysis of signalling pathways also relied on the test of neutrophils from patients with deficiencies in pathways important for NET induction (CGD patients, and an MPO-deficient individual) along with primary healthy neutrophils treated with small molecule inhibitors of proteins required for PMA-induced NETosis. The authors also demonstrate that while apoptosis, necrosis and necroptosis can be induced in primary healthy neutrophils these pathways do not result in NET formation. Also inhibiting the induction of these cell death pathways has no effect on NETosis thus verifying that NETosis is a novel cell death pathway.

Essential revisions:

The reviewers found the work interesting and important. It clarifies that the pathways involved in NET formation vary depending on the stimulus to which neutrophils are exposed. However, at the same time some important questions arose which need to be carefully addressed:

1\) One very interesting finding described in the manuscript is the effect of *C. albicans* on NET formation by CGD neutrophils. From their data, the authors conclude that *C. albicans* provided ROS for NET formation. They hypothesise that this might be the difference to *A. fumigatus* and explain why CGD patients are more susceptible to invasive aspergillosis rather than to a *C. albicans* infection. I think the data are suggestive for this conclusion. However, it would add strength if the authors had some experimental hints. It is most likely that ROS derive from the NADPH oxidase complex present in *C. albicans*. Possibly, the authors could carry out an experiment in which the NADPH oxidase is inhibited by DPI in *C. albicans* and such cells are used for the co-incubation experiment. Alternatively, an NADPH oxidase mutant of *C. albicans* could be used.

2\) [Figure 6](#fig6){ref-type="fig"}: Why are there 2 bands for the A23 lane of citrullinated H3?

3\) Depending on the donor, netting neutrophils appear to differ in their ability to downregulate NET formation in response to PAD inhibitors. It would be important to expand the PAD inhibitor experiments to about 10 healthy controls. In addition, it was found that difference sources of PAD inhibitors may differ in their ability to inhibit NETosis. As Cl^-^amidine has been shown by several groups to inhibit NETs in human neutrophils obtained from individuals with various inflammatory conditions as well as healthy controls (Smith CK A&R 2014; Subramaniam V J Med Chem 2015; Kusunoki Y. Front Immunol 2016; Rocha et al. Science Rep 2015; Hosseinzadeh et al. JLB 2016; Khandpur. ScienceTrans Med 2013), perhaps adding this compound to in vitro experiments would also be helpful.

4\) A time course would be good. Especially at quite early times to see how quickly molecules like the ionophore release NETs.

5\) Do all of these stimuli induce significant LDH release?

6\) Do all of the stimuli induce the same quality of NETs? For example do they all have the same proteolytic activity?

7\) Are all of the NETs equally capable of killing bacteria?

8\) Are all of the NETs primarily from nuclear rather than mitochondrial material?

9\) Include the demographics of the donors.

10.7554/eLife.24437.032

Author response

Essential revisions:

The reviewers found the work interesting and important. It clarifies that the pathways involved in NET formation vary depending on the stimulus to which neutrophils are exposed. However, at the same time some important questions arose which need to be carefully addressed:

1\) One very interesting finding described in the manuscript is the effect of C. albicans on NET formation by CGD neutrophils. From their data, the authors conclude that C. albicans provided ROS for NET formation. They hypothesise that this might be the difference to A. fumigatus and explain why CGD patients are more susceptible to invasive aspergillosis rather than to a C. albicans infection. I think the data are suggestive for this conclusion. However, it would add strength if the authors had some experimental hints. It is most likely that ROS derive from the NADPH oxidase complex present in C. albicans. Possibly, the authors could carry out an experiment in which the NADPH oxidase is inhibited by DPI in C. albicans and such cells are used for the co-incubation experiment. Alternatively, an NADPH oxidase mutant of C. albicans could be used.

The reviewer raises an interesting point, to address it we treated the *C. albicans* with 10 µM pyrocatechol during the 30 minute opsonisation step prior to NET induction. This new data is shown in [Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"} and described in the fourth paragraph of the subsection "Differential ROS requirements of NETs". It revealed that blocking ROS in *C. albicans* also reduced the amount of NETs generated by healthy neutrophils. Moreover, pre-treating the neutrophils with pyrocatechol and then adding *C. albicans* that were pre-treated with the ROS scavenger as well resulted in even greater NET inhibition. This demonstrates that fungus generated ROS can contribute to make NETs.

Interestingly, it was recently demonstrated that CGD patients produce significantly less NETs in response to *A. fumigatus* than to *C. albicans* (Gazendam et al., 2016). This data addresses the observation of the reviewer on the susceptibility to *A. fumigatus* and *C. albicans* in CGD patients and is now discussed in the fifth paragraph of the Discussion.

2\) [Figure 6](#fig6){ref-type="fig"}: Why are there 2 bands for the A23 lane of citrullinated H3?

The reviewer correctly points out that this blot is confusing to the reader. Therefore, we included new data showing that during the process of NETosis histone H3 is processed by granule proteases. In the new version of the manuscript we show ([Figure 7A](#fig7){ref-type="fig"} and subsection "All stimuli induce NETs that are proteolytically active, kill bacteria and are composed primarily of nuclear DNA", first paragraph) that histone H3 is cleaved 90 minutes post stimulation in response to all stimuli. These data show that the two bands seen in response to A23187 stimulation are the result of histone cleavage.

3\) Depending on the donor, netting neutrophils appear to differ in their ability to downregulate NET formation in response to PAD inhibitors. It would be important to expand the PAD inhibitor experiments to about 10 healthy controls. In addition, it was found that difference sources of PAD inhibitors may differ in their ability to inhibit NETosis. As Cl^-^amidine has been shown by several groups to inhibit NETs in human neutrophils obtained from individuals with various inflammatory conditions as well as healthy controls (Smith CK A&R 2014; Subramaniam V J Med Chem 2015; Kusunoki Y. Front Immunol 2016; Rocha et al. Science Rep 2015; Hosseinzadeh et al. JLB 2016; Khandpur. ScienceTrans Med 2013), perhaps adding this compound to in vitro experiments would also be helpful.

The reviewer correctly points out a discrepancy in the field and we followed his/her suggestion. To address this comment we tested the three PAD inhibitors on neutrophils from 10 independent healthy donors. As shown in [Figure 6E](#fig6){ref-type="fig"} and described in the second paragraph of the subsection "Histone citrullination occurs but is not required for NET induction", pre-treatment of the cells with the Cl^-^amidine PAD inhibitor had no effect on NETosis. This was also true for cells pre-treated with BB-Cl^-^amidine ([Figure 6F](#fig6){ref-type="fig"}) and TDFA ([Figure 6G](#fig6){ref-type="fig"}). The data shown in [Figure 6](#fig6){ref-type="fig"} is the mean ± SEM of the 10 independent experiments. These experiments are also shown individually in [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"} which confirm that these inhibitors do not affect NET induction in response to any of the stimuli tested.

As an important control, we also included data showing that the Cl^-^amidine blocks citrullination of histone H3 in response to A23187, *C. albicans* and GBS stimulation ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). This demonstrates that the compound was active under our experimental conditions.

4\) A time course would be good. Especially at quite early times to see how quickly molecules like the ionophore release NETs.

This is a helpful suggestion by the reviewer and the data are now included in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} and are described in the second paragraph of the subsection "A wide range of stimuli induce Neutrophil Extracellular Traps (NETs)". These data show that all 5 stimuli tested generate NETs over a 3-4 hour time course.

5\) Do all of these stimuli induce significant LDH release?

We addressed this relevant question and show in [Figure 8---figure supplement 1E](#fig8s1){ref-type="fig"} that all five stimuli induce LDH release in the process of making NETs. This is described in the second paragraph of the subsection "NETosis is distinct from other forms of cell death".

6\) Do all of the stimuli induce the same quality of NETs? For example do they all have the same proteolytic activity?

The reviewer raises interesting questions about the quality of the NETs in this and the next two questions. To address proteolytic activity we examined the ability of neutrophils to degrade histone H3 during NETosis and show that all 5 stimuli lead to degradation within 90 minutes as shown in [Figure 7A](#fig7){ref-type="fig"}. We also isolated the NETs produced in response to the 5 stimuli and tested their ability to breakdown FITC-labelled casein using the Pierce Fluorescent Protease Assay Kit (Thermo scientific) as directed in the manufacturer's instructions. This data are shown in [Figure 7B](#fig7){ref-type="fig"} and described in the first paragraph of the subsection "All stimuli induce NETs that are proteolytically active, kill bacteria and are composed primarily of nuclear DNA".

7\) Are all of the NETs equally capable of killing bacteria?

To address this question we include a new [Figure 7C](#fig7){ref-type="fig"} which is described in the second paragraph of the subsection "All stimuli induce NETs that are proteolytically active, kill bacteria and are composed primarily of nuclear DNA". In this experiment we induced NETs and 4 hours later treated the neutrophils with Cytochalasin D to inhibit phagocytosis. We included samples treated with DNase 1 at 50U/ml to degrade the NETs. Tetracycline resistant *E. coli* (XL1-Blue, Stratagene. Used to differentiate between the GBS, *C. albicans* and *E. coli* growth on agar plates) at a MOI of 1 was added to the cells/NETs and incubated at 37°C for 1 hour. The cells and *E. coli* were then scrapped and collected. One set of samples were sonicated to release any bacteria trapped by the NETs and unavailable for counting. Finally serial dilutions were carried out and the *E. coli* were plated on agar plates containing tetracycline, incubated at 37°C for 24 hr before counting. The data showed that all NETs produced killed *E. coli*.

8\) Are all of the NETs primarily from nuclear rather than mitochondrial material?

In the new version of the manuscript, we include [Figure 7D](#fig7){ref-type="fig"} and described the results in the third paragraph of the subsection "All stimuli induce NETs that are proteolytically active, kill bacteria and are composed primarily of nuclear DNA". This figure shows that all NETs generated are primarily composed of nuclear DNA.

9\) Include the demographics of the donors.

The demographics of the CGD patients has been included in [Table 1. A](#tbl1){ref-type="table"} statement on the source of the healthy blood donors stating that blood was anonymously collected at the Charité hospital, Berlin has also been included in the Materials and methods subsection "Donor consent".
